HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pierre I Karakiewicz Selected Research

Margins of Excision

10/2020Prognostic Value of Gleason Score at Positive Surgical Margin in Prostate Cancer: A Systematic Review and Meta-analysis.
1/2020Impact of hospital and surgeon volumes on short-term and long-term outcomes of radical cystectomy.
2/2019Rates of Positive Surgical Margins and Their Effect on Cancer-specific Mortality at Radical Prostatectomy for Patients With Clinically Localized Prostate Cancer.
1/2019Propensity-score-matched comparison of soft tissue surgical margins status between open and robotic-assisted radical cystectomy.
12/2018Clinical value of cholinesterase in the prediction of biochemical recurrence after radical prostatectomy.
1/2018Tertiary Gleason pattern in radical prostatectomy specimens is associated with worse outcomes than the next higher Gleason score group in localized prostate cancer.
8/2017External Validation of the Pathologic Nodal Staging Score for Prostate Cancer: A Population-based Study.
2/2016Evaluation of positive surgical margins in patients undergoing robot-assisted and open radical prostatectomy according to preoperative risk groups.
1/2016Differences in Patient Characteristics Among Men Choosing Open or Robot-Assisted Radical Prostatectomy in Contemporary Practice at a European High-Volume Center.
2/2015Validation of tertiary Gleason pattern 5 in Gleason score 7 prostate cancer as an independent predictor of biochemical recurrence and development of a prognostic model.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Pierre I Karakiewicz Research Topics

Disease

299Prostatic Neoplasms (Prostate Cancer)
10/2022 - 02/2002
299Neoplasms (Cancer)
09/2022 - 04/2002
174Carcinoma (Carcinomatosis)
09/2022 - 02/2006
107Urinary Bladder Neoplasms (Bladder Cancer)
12/2022 - 02/2005
96Renal Cell Carcinoma (Grawitz Tumor)
07/2022 - 06/2007
55Neoplasm Metastasis (Metastasis)
03/2022 - 06/2005
39Lymphatic Metastasis
08/2022 - 10/2006
38Margins of Excision
10/2020 - 12/2005
20Disease Progression
05/2021 - 09/2007
18Kidney Neoplasms (Kidney Cancer)
08/2022 - 10/2007
17Carcinoma in Situ
01/2019 - 09/2006
17Transitional Cell Carcinoma
04/2014 - 05/2005
16Non-Muscle Invasive Bladder Neoplasms
05/2022 - 05/2010
11Adenocarcinoma
01/2021 - 05/2007
11Extranodal Extension
01/2017 - 12/2005
9Obesity
01/2021 - 08/2007
8Intraoperative Complications
01/2018 - 04/2012
7Necrosis
01/2022 - 04/2010
6Inflammation (Inflammations)
06/2022 - 01/2020
6Urinary Incontinence
11/2021 - 03/2008
6Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2021 - 02/2012
6Erectile Dysfunction
01/2021 - 01/2006
5Carcinogenesis
04/2022 - 01/2008
5Frailty
01/2022 - 03/2020
5Hypertension (High Blood Pressure)
07/2021 - 09/2009
4Renal Insufficiency (Renal Failure)
01/2019 - 06/2009
4Diabetes Mellitus
08/2014 - 08/2009
3Urinary Bladder Neck Obstruction (Bladder Neck Obstruction)
09/2022 - 06/2008
3Rectal Neoplasms (Rectal Cancer)
12/2019 - 02/2010
3Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
12/2019 - 08/2009
3Anemia
06/2019 - 09/2009
3Wounds and Injuries (Trauma)
01/2019 - 04/2007
2Injection Site Reaction
01/2022 - 01/2021

Drug/Important Bio-Agent (IBA)

58Prostate-Specific Antigen (Semenogelase)IBA
01/2022 - 03/2002
36Biomarkers (Surrogate Marker)IBA
03/2022 - 02/2007
23AndrogensIBA
04/2022 - 06/2005
12AntigensIBA
12/2022 - 03/2008
9GlobulinsIBA
03/2022 - 08/2020
9Indicators and Reagents (Reagents)IBA
01/2022 - 04/2010
9Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
11/2021 - 03/2008
9Biological ProductsIBA
10/2019 - 03/2008
8AlbuminsIBA
03/2022 - 08/2020
7Hormones (Hormone)IBA
01/2022 - 04/2006
7Interleukin-6 (Interleukin 6)IBA
01/2022 - 03/2008
7Sunitinib (Sutent)FDA Link
01/2021 - 06/2007
7Plasminogen Activators (Plasminogen Activator)IBA
01/2021 - 03/2008
7nuclear matrix protein 22IBA
03/2012 - 05/2005
6EndoglinIBA
01/2022 - 03/2008
6Proteins (Proteins, Gene)FDA Link
01/2022 - 05/2007
6Tyrosine Kinase InhibitorsIBA
01/2022 - 02/2012
5isopropyl cyanoacrylateIBA
09/2022 - 08/2008
5Caveolin 1IBA
08/2022 - 05/2007
5Immune Checkpoint InhibitorsIBA
07/2022 - 01/2021
5Gonadotropin-Releasing Hormone (GnRH)FDA Link
01/2022 - 08/2014
5Serum AlbuminIBA
10/2021 - 01/2021
5C-Reactive ProteinIBA
01/2021 - 09/2007
5Dihydrotachysterol (AT 10)IBA
01/2021 - 02/2009
5SurvivinIBA
11/2015 - 02/2007
5temsirolimusFDA Link
04/2014 - 05/2008
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022 - 06/2008
4enzalutamideIBA
01/2022 - 01/2018
4Urokinase Plasminogen Activator ReceptorsIBA
10/2020 - 06/2009
4Metformin (Glucophage)FDA LinkGeneric
10/2018 - 12/2013
4Cadherins (E-Cadherin)IBA
08/2017 - 11/2011
4Cisplatin (Platino)FDA LinkGeneric
05/2015 - 06/2008
3Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
08/2022 - 06/2008
3EnzymesIBA
04/2022 - 06/2008
3Docetaxel (Taxotere)FDA Link
01/2022 - 01/2018
3abirateroneIBA
01/2022 - 01/2018
3pembrolizumabIBA
01/2022 - 01/2020
3PlasminogenIBA
01/2021 - 10/2007
3Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2021 - 07/2013
3Hemoglobins (Hemoglobin)IBA
08/2020 - 08/2019
3Cholinesterases (Cholinesterase)IBA
01/2019 - 12/2018
3InterferonsIBA
01/2018 - 08/2006
3EverolimusFDA Link
01/2015 - 04/2011
3Sorafenib (BAY 43-9006)FDA Link
12/2009 - 05/2008
3Transforming Growth Factor beta1 (TGF beta 1)IBA
06/2009 - 04/2008
2Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
11/2022 - 11/2008

Therapy/Procedure

245Prostatectomy (Retropubic Prostatectomy)
10/2022 - 02/2002
145Cystectomy
09/2022 - 02/2005
123Therapeutics
07/2022 - 06/2005
92Lymph Node Excision (Lymph Node Dissection)
01/2022 - 05/2006
91Nephrectomy
08/2022 - 04/2007
73Radiotherapy
06/2022 - 08/2006
73Nephroureterectomy
01/2022 - 10/2008
45Drug Therapy (Chemotherapy)
06/2022 - 04/2006
31Adjuvant Chemotherapy
04/2017 - 10/2006
22Length of Stay
02/2022 - 08/2011
15Neoadjuvant Therapy
05/2022 - 10/2006
13Blood Transfusion (Blood Transfusions)
01/2022 - 04/2007
10Adjuvant Radiotherapy
10/2019 - 10/2006
9Immunotherapy
03/2022 - 12/2012
7Castration
01/2022 - 01/2019
7Brachytherapy
01/2022 - 12/2015
7Transurethral Resection of Bladder
01/2022 - 03/2013
4Transurethral Resection of Prostate (TURP)
09/2022 - 08/2009
4Aftercare (After-Treatment)
01/2022 - 08/2016
4Catheters
11/2021 - 06/2011
4Orchiectomy (Orchidectomy)
12/2019 - 12/2014